Pat Alagia

Special Episode: Trends in drug testing resulting from the COVID-19 pandemic

The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic.
In this session, Dr Gudin discusses with Dr Pat Alagia on the Quest Dialogues podcast:
Recently-published data by Quest that demonstrates decreased drug testing overall, with increased positivity for high-risk drugs and dangerous drug combinations 
Tools and practices for clinicians to assess and stratify patients for potential prescription drug abuse
System-level strategies that employ an integrated care delivery approach, including leveraging community and diagnostics partnerships, to support impacted patient populations